Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

Published 2008 View Full Article

Authors

Keywords

Journal

LANCET NEUROLOGY

Volume 7, Issue 5, Pages 400-408

Publisher

Elsevier BV

Online

2008-04-03

DOI

10.1016/s1474-4422(08)70065-6

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

LANCET NEUROLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Become a Peeref-certified reviewer